Publications by authors named "Esraa G Sayed"
Introduction: Endometrial hyperplasia is associated with varying risk of endometrial cancer. The aim of this review is to assess effectiveness of levonorgestrel-releasing intrauterine system (LNG-IUS), compared to systemic progestins, in management of endometrial hyperplasia MATERIALS AND METHODS: A search on studies comparing LNG-IUS to systemic progestins was conducted on Scopus, Web of science, Cochrane, PubMed and Embase databases, from the date of inception to September 20, 2020. Studies were excluded if they were non-comparative, animal studies, review articles, case reports, case series, and conference papers.
View Article and Find Full Text PDFObjective: To appraise clinical outcomes of systematic lymphadenectomy in women with ovarian cancer based on stage, control group and type of chemotherapy.
Study Design: A literature search was conducted on SCOPUS, PUBMED, COCHRANE, MEDLINE, and WEB OF SCIENCE databases. All comparative studies that assess outcomes of systematic lymphadenectomy in patients with ovarian cancer were eligible.
Objective: To validate the use of placenta accreta risk-antepartum (PAR-A) score as a predictive tool of clinical outcomes of placenta accreta spectrum (PAS).
Methods: This is a prospective study, conducted in six PAS specialized centers in six different countries. The study was conducted between October 1, 2020 and March 31, 2021.
Since the 50 s of the last century, labor charts have been proposed and appraised as a tool to diagnose labor abnormalities and guide decision-making. The partogram, the most widely adopted form of labor charts, has been endorsed by the world health organization (WHO) since 1994. Nevertheless, recent studies and systematic reviews did not support clinical significance of application of the WHO partogram.
View Article and Find Full Text PDFArticle Synopsis
- High-intensity focused ultrasound (HIFU) is a non-invasive treatment being evaluated for managing placenta accreta spectrum (PAS).
- A systematic review of studies up to January 2020 found that HIFU was successful in all tested cases, with an average recovery time for menstruation of about 49 days and no major complications reported.
- The study emphasizes the need for a unified global research approach to integrate HIFU and other conservative treatment methods into a comprehensive management protocol for PAS.